Q1 2014 13F Holders as of 3/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
25.8M
-
Shares change
-
+1.69M
-
Total reported value, excl. options
-
$1.14B
-
Value change
-
+$79.4M
-
Put/Call ratio
-
0.53
-
Number of buys
-
66
-
Number of sells
-
-45
-
Price
-
$44.07
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q1 2014
125 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q1 2014.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.8M shares
of 374M outstanding shares and own 6.9% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (3.48M shares), JENNISON ASSOCIATES LLC (3.02M shares), WASATCH ADVISORS INC (1.71M shares), ORBIMED ADVISORS LLC (1.45M shares), FMR LLC (1.35M shares), JPMORGAN CHASE & CO (1.31M shares), LORD, ABBETT & CO. LLC (1.3M shares), NEXT CENTURY GROWTH INVESTORS LLC (1.09M shares), FRANKLIN RESOURCES INC (1.08M shares), and VANGUARD GROUP INC (802K shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.